Policy & Medicine
Legal, Regulatory, and Compliance Issues
Close the sidebar
Browsing tag
surrogate endpoints
HHS OIG Reviews FDA’s Accelerated Approval of Aducanumab
Read more
IOM: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Read more
